Cargando…
De novo design of protein peptides to block association of the SARS-CoV-2 spike protein with human ACE2
The outbreak of COVID-19 has now become a global pandemic that has severely impacted lives and economic stability. There is, however, no effective antiviral drug that can be used to treat COVID-19 to date. Built on the fact that SARS-CoV-2 initiates its entry into human cells by the receptor binding...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343451/ https://www.ncbi.nlm.nih.gov/pubmed/32544884 http://dx.doi.org/10.18632/aging.103416 |